BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 8874763)

  • 1. Cytokines in the treatment of hematological disorders: recent progress and perspectives.
    Robak T
    Arch Immunol Ther Exp (Warsz); 1996; 44(1):5-9. PubMed ID: 8874763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cytokines in the treatment of blood diseases].
    Robak T
    Acta Haematol Pol; 1995; 26(2 Suppl 1):72-8. PubMed ID: 7544526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine therapy for hematological malignancies.
    Ezaki K; Tsuzuki M
    Gan To Kagaku Ryoho; 1997 May; 24 Suppl 1():182-94. PubMed ID: 9210900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Present state and perspective of cytokine research].
    Takaku F
    Hum Cell; 1993 Jun; 6(2):75-81. PubMed ID: 7692952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
    Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G
    Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine-primed bone marrow stem cells vs. peripheral blood stem cells for autologous transplantation: a randomized comparison of GM-CSF vs. G-CSF.
    Weisdorf D; Miller J; Verfaillie C; Burns L; Wagner J; Blazar B; Davies S; Miller W; Hannan P; Steinbuch M; Ramsay N; McGlave P
    Biol Blood Marrow Transplant; 1997 Oct; 3(4):217-23. PubMed ID: 9360784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokines in the pathogenesis and management of non-Hodgkin's lymphomas.
    Cicco NA; Lübbert M; Oster W; Lindemann A; Mertelsmann R
    Hematol Oncol Clin North Am; 1991 Oct; 5(5):1053-66. PubMed ID: 1938755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Status of recombinant cytokines in treatment of leukemic diseases].
    Geissler K
    Wien Med Wochenschr; 1991; 141(9-10):217-20. PubMed ID: 1949848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine therapy for hematological malignancies.
    Ezaki K
    Int J Hematol; 1996 Dec; 65(1):17-29. PubMed ID: 8990622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interferons, a class of cytokines with a large therapeutic activity range].
    Billard C
    Bull Cancer; 1993 Sep; 80(9):741-56. PubMed ID: 7515733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of biotherapy in multiple myeloma].
    Petrucci MT; Tafuri A; Mandelli F
    Recenti Prog Med; 2000 Oct; 91(10):488-93. PubMed ID: 11072735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-3 in the clinic.
    Eder M; Geissler G; Ganser A
    Stem Cells; 1997; 15(5):327-33. PubMed ID: 9323793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic immunomodulation.
    Galbraith GM
    Dermatol Clin; 1988 Oct; 6(4):561-8. PubMed ID: 2465856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New directions in hematologic biotherapy.
    Groopman JE
    Semin Hematol; 1989 Jul; 26(3 Suppl 3):1-6. PubMed ID: 2477903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current status of the clinical application of hematopoietic growth factors in oncology].
    Karthaus M; Ganser A
    Ther Umsch; 1996 Nov; 53(11):863-73. PubMed ID: 8984692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment with growth factors and cytokines in hematologic diseases].
    Waage A; Dahl IM; Evensen SA; Holte H; Lamvik J; Sletnes K; Wisløff F
    Tidsskr Nor Laegeforen; 1996 May; 116(12):1465-9. PubMed ID: 8650635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulocyte-macrophage-colony-stimulating factor and other cytokines: as adjuncts to cancer immunotherapy, stem cell transplantation, and vaccines.
    Arellano M; K Waller E
    Curr Hematol Rep; 2004 Nov; 3(6):424-31. PubMed ID: 15496276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-3 in hematology and oncology: current state of knowledge and future directions.
    Mangi MH; Newland AC
    Cytokines Cell Mol Ther; 1999 Jun; 5(2):87-95. PubMed ID: 10515681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GM-CSF accelerates neutrophil recovery after autologous hematopoietic stem cell transplantation.
    Greenberg P; Advani R; Keating A; Gulati SC; Nimer S; Champlin R; Karanes C; Gorin NC; Powles RL; Smith A; Lamborn K; Cuffie C
    Bone Marrow Transplant; 1996 Dec; 18(6):1057-64. PubMed ID: 8971373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Collection of peripheral blood progenitor cells for autografting with low-dose cyclophosphamide plus granulocyte colony-stimulating factor.
    Bellido M; Sureda A; Martino R; Madoz P; García J; Brunet S
    Haematologica; 1998 May; 83(5):428-31. PubMed ID: 9658727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.